Skip to main content
Livermore
Livermore
ZHEN

Natixis

SEC CIK
0001274981
Latest filing
Aug 13, 2026

DXCM holding history

Dexcom Inc in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DXCM overviewAll 13F holders of DXCMFull Q2 2026 holdings

Shares (Q2 2026)
20,105
Value
$1.35M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of DXCM by Natixis, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202620,105$1.35M<0.1%−63,601−76.0%ReducedHolders
Q1 202683,706$5.26M<0.1%+5,845+7.5%AddedHolders
Q4 202577,861$5.17M<0.1%−28,973−27.1%ReducedHolders
Q3 2025106,834$7.19M<0.1%+44,121+70.4%AddedHolders
Q2 202562,713$5.47M<0.1%+42,962+217.5%AddedHolders
Q1 202519,751$1.34M<0.1%−11,119−36.0%ReducedHolders
Q4 202430,870$2.40M<0.1%−126,994−80.4%ReducedHolders
Q3 2024157,864$10.6M0.1%+68,073+75.8%AddedHolders
Q2 202489,791$10.2M0.1%+81,791+1,022.4%AddedHolders
Q1 20248,000$1.11M<0.1%+1,600+25.0%AddedHolders
Q4 20236,400$794.2K<0.1%+6,400NewHolders
Q1 20230$00.0%−59,549−100.0%Sold outHolders
Q4 202259,549$6.74M<0.1%+570+1.0%AddedHolders
Q3 202258,979$4.81M<0.1%−21,223−26.5%ReducedHolders
Q2 202280,202$5.99M<0.1%−516,838−86.6%ReducedConverted for a 4-for-1 splitHolders
Q1 2022149,260$76.4M0.3%−36,449−19.6%ReducedHolders
Q4 2021185,709$99.7M0.3%+52,360+39.3%AddedHolders
Q3 2021133,349$72.9M0.3%+57,052+74.8%AddedHolders
Q2 202176,297$32.6M0.1%+38,964+104.4%AddedHolders
Q1 202137,333$13.4M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.